Innovus Pharma Selects Lebanese-Canadian Hospital for Its Post-Marketing Clinical Trials for CIRCUMserum and EjectDelay
Published: Nov 11, 2013
LA JOLLA, Calif., Nov. 11, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company") www.innovuspharma.com (OTCBB:INNV) today announced that the Company selected the Lebanese-Canadian Hospital in Beirut, Lebanon for its two post-marketing trials for CIRCUMserum™ to alleviate reduced penile sensitivity and EjectDelay™ for premature ejaculation.
Help employers find you! Check out all the jobs and post your resume.